Moreover, MELK overexpression promotes endometrial carcinoma progression by modulating the E2F transcription factor 1 (E2F1) protein and activating the mTORC1 (mammalian transducer of regulated cAMP response element-binding protein) and mTORC2 signaling pathways [2]. Here, E2F1 is linked to endometrial carcinoma.